Table 1: Overall Financial Performance Unit: million baht Jan-Sep 2018 % Jan-Sep 2019 % Change % YoY Revenue 380.50 100.0% 440.78 100.0% 60.28 15.8% Cost 217.33 57.1% 238.03 54.0% 20.70 9.5% Gross Profit
expansion. Total Liabilities As of 31 March 2018, total liabilities of the company and its subsidiaries stood at Baht 13,631 million, slightly up from those of 31 December 2017. Major change in liabilities is
change from the same period of prior year. Gross Margin for construction service still be the same as previous year. As at 30 June 2017, the Group has backlog for construction service in oil and gas sector
the C t showed a at 91.9 perc rofit was a ts receivabl was 296.8 presents th e details of Q3/2560 Q MB. 60.5 288.9 1.0 350.4 d Analysis, land (“the Comp s and perfor 0 Septembe be summariz Company’s net
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the
. Revenue from sales 3-month period ending Change 9-month period ending Change Unit: THB million 30 Sep 16 30 Sep 17 Amount (%) 30 Sep 16 30 Sep 17 Amount (%) Branded products by our own manufacture 1/ 1,730
31.0% EBIT -37 -23 -14 -60.9% 312 52 260 500.8% Net profit (loss) -60 -55 -5 -9.9% 170 -23 193 840.6% EPS (THB) -0.072 -0.065 -0.006 -9.9% 0.202 -0.027 0.229 840.6% Change Change Dusit Thani PLC
amount of 14,080.10 million baht compared to at the end of year 2017 equivalent to 11,780.10 million baht, which increased of 2,300 million baht or 19.5%. There was thus the significant change of the
in debt collection which the collection rate has increased by 97.2% at the end of March 2018. The Company expected that its performance in the first quarter of this year would be the lowest of
retrospectively. The significant principles are as follows:- Derivative financial instruments are used to manage exposure to foreign exchange and interest rate risks, which are recognized initially at fair value